No Data
No Data
HeFu China (603122.SH) will distribute cash dividends for the year 2023 on June 21, with a dividend of 0.06 yuan per share.
Hefu China (603122.SH) announced that it will distribute the annual report for 2023 on June 21, 2024.
By May 2024, the cumulative consolidated revenue of Hefu China (603122.SH) decreased by 13.26% year-on-year.
On June 7th, Gelunhui reported that the company's cumulative merged revenue for January-May 2024 was RMB 406 million, a 13.26% decrease from the same period last year.
Cowealth Medical China's Operating Income Falls 11% in January-April
Cowealth Medical China (SHA:603122) recorded a consolidated operating income of between January and April, sliding 11.12% from the prior year. Shares of the company fell nearly 2% in recent trade.
Hefu China (603122.SH): The cumulative consolidated revenue for January-April was 330 million yuan, a year-on-year decrease of 11.12%
On May 9, Ge Longhui China (603122.SH) announced that the company's cumulative consolidated revenue from January to April 2024 was RMB 332.672 million, down 11.12% from the consolidated revenue for the same period last year.
Hefu China (603122.SH) announced first-quarter results, net profit of 7.13 million yuan, a year-on-year decrease of 22.65%
Hefu China (603122.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 2.3 during the reporting period...
Capital Allocation Trends At Cowealth Medical ChinaLtd (SHSE:603122) Aren't Ideal
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'll want to see a proven return on capital employ
No Data